NCT02372110 is a Phase 4 clinical trial of HPA, ANS stimulation in Anxiety, sponsored by University of Texas at Austin.

Who is sponsoring NCT02372110?

NCT02372110 is sponsored by University of Texas at Austin.

What drugs are being tested in NCT02372110?

Interventions in NCT02372110: HPA, ANS stimulation, Placebo.

Is NCT02372110 still recruiting?

NCT02372110 is currently completed. Last updated 26 April 2021.

Last reviewed 2021-04-26 · How we verify

NCT02372110

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response

Completed Phase 4 Last updated 26 April 2021

What this trial tests

Phase 4 trial testing HPA, ANS stimulation in Anxiety in 120 participants. Completed in 1 November 2015.

Timeline

1 March 2015

Primary endpoint
1 November 2015

1 November 2015

Quick facts

Lead sponsor	University of Texas at Austin
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	basic science
Enrollment	120
Start date	1 March 2015
Primary completion	1 November 2015
Estimated completion	1 November 2015
Sites	1 location across United States

Drugs / interventions tested

HPA, ANS stimulation — full drug profile →
Placebo

Conditions studied

Anxiety — all drugs for Anxiety →

Sponsor

University of Texas at Austin

Who can join

18 and older, any sex, with Anxiety. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Heart Rate
Time frame: 180 minutes
continuous heart rate monitoring

Sponsor's own description

The proposed study aims to investigate experimentally anxiety sensitivity and physiologic sensations associated with anxiety using a paradigm combining hydrocortisone, caffeine, and a set of social stress challenges. Following informed consent, participants will be instructed to ingest either 400 milligrams of caffeine (an amount of caffeine roughly equivalent to that in two 8 oz. cups of brewed coffee from Starbucks), and 20 milligrams of hydrocortisone or two placebo capsules via stratified, random assignment. Physiologic and self-reported measures of stress and anxiety will be taken.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting

Other University of Texas at Austin trials

Trials by the same sponsor.

NCT07319234 — Development of MENU Protocol · NA · not yet recruiting
NCT07480109 — Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) · NA · not yet recruiting
NCT07069413 — Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children · NA · not yet recruiting
NCT07370311 — A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisi · NA · not yet recruiting
NCT07441122 — Enhancing Attention in Elderly Using a Brain-Computer-Interface · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02372110 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas at Austin
Last refreshed: 26 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02372110.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing